Cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31182708.
- Also identified by DOI 10.1038/s41467-019-10386-8 and PMC identifier 6557849.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The pathological mechanisms of radiation ulcer remain unsolved and there is currently no effective medicine. Here, we demonstrate that persistent DNA damage foci and cell senescence are involved in radiation ulcer development. Further more, we identify cordycepin, a natural nucleoside analogue, as a potent drug to block radiation ulcer (skin, intestine, tongue) in rats/mice by preventing cell senescence through the increase of NRF2 nuclear expression (the assay used is mainly on skin). Finally, cordycepin is also revealed to activate AMPK by binding with the α1 and γ1 subunit near the autoinhibitory domain of AMPK, then promotes p62-dependent autophagic degradation of Keap1, to induce NRF2 dissociate from Keap1 and translocate to the nucleus. Taken together, our findings identify cordycepin prevents radiation ulcer by inhibiting cell senescence via NRF2 and AMPK in rodents, and activation of AMPK or NRF2 may thus represent therapeutic targets for preventing cell senescence and radiation ulcer.
Medical subject headings
- AMP-Activated Protein Kinases
- Cellular Senescence
- DNA Damage
- Deoxyadenosines
- NF-E2-Related Factor 2
- Radiation Injuries, Experimental
- Ulcer